2022 Meeting Agenda (All Times Pacific)Join Now

Wednesday, November 2, 2022

HYPORESOLVE - MEASURING HYPOGLYCEMIA AND ITS IMPACT (1.5 CME Credits)free Recording

7:30

Moderators

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

Michael A. Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA

7:30

Overview of HypoMETRICS

Pratik Choudhary, FRCP, MD, MRCP, MBBS
University of Leicester, Leicester, UK

7:45

Developing and Validating the HypoMETRICS App

Natalie Zaremba, MSc
King’s College London, London, UK

8:00

Symptomatic Hypoglycemia in the Age of CGM

Patrick M. Divilly, MB, BAO, BCh, MRCPI
King’s College London, London, UK

8:20

Developing an Objective Tool to Assess Hypoglycaemia Awareness

Gilberte Martine-Edith, PhD
King’s College London, London, UK

8:40

Q&A / Panel Discussion

9:00

Break

ONCE-WEEKLY INSULINS (1.5 CME Credits)free Recording

9:15

Once-Weekly Insulins – Where Are We Now?

Chantal Mathieu, MD, PhD
Catholic University of Leuven, Leuven, Belgium

9:30

Insulin Icodec Basal Switch Trial, ONWARDS 2

Athena Philis-Tsimikas, MD
Scripps Health, San Diego, California, USA

9:50

Insulin Icodec Basal Bolus Trial, ONWARDS 4

Chantal Mathieu, MD, PhD
Catholic University of Leuven, Leuven, Belgium

10:10

Once-Weekly Insulins – What’s Coming?

Harpreet S. Bajaj, MD, MPH, FACE
LMC Healthcare, Brampton, Ontario, Canada

10:25

Q&A / Panel Discussion

10:45

Break

MEET THE PROFESSORS (Non-Accredited Education)

14:00

Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

14:30

Mark A. Arnold, PhD
University of Iowa, Iowa City, Iowa, USA

15:00

Steven V. Edelman, MD
University of California, San Diego, San Diego, California, USA

15:30

End of Session

Thursday, November 3, 2022

WORKSHOP A: MEASUREMENT OF GLUCOSE, INSULIN, AND KETONES

PANEL 1: MEASUREMENT OF GLUCOSE (Non-Accredited Education)

What new developments for measuring glucose are most likely to be widely adopted?

8:00

Moderators

John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK

Howard Wolpert, MD
Boston Medical Center, Cambridge, Boston, USA

8:05

Development of a Self-Powered Diaper Glucose Sensor Combining a Low Power Wireless Transmission Device and a Paper Substrate Biofuel Cell

Isao Shitanda, PhD
Tokyo University of Science, Noda-shi, Chiba, Japan

8:20

Traceability of CGMs

Guido Freckmann, MD
Institute for Diabetes Technology Research at Ulm University, Ulm, Germany

8:35

Advances in the Noninvasive Sensing of Glucose in People

Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA

8:50

Dynamic Interference Testing of CGM Sensors

Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany

9:05

CGM Accuracy - Clinical Trials vs. Real-World Data

Jan S. Krouwer, PhD
Krouwer Counseling, Sherborn, Massachusetts, USA

9:20

Q&A / Panel Discussion

9:45

Break

PANEL 2: MEASUREMENT OF INSULIN AND KETONES (Non-Accredited Education)

What new developments for measuring insulin and ketones are most likely to be widely adopted?

10:10

Moderators

Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA

Kirsten Nørgaard, MD, DMSc
Steno Diabetes Center Copenhagen, Herlev, Denmark

10:15

Current Technology Development to Realize Continuous Insulin Monitoring System

Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

10:30

The Development of the Disposable and Highly Reproducible Insulin Sensing Point of Care Technology

Jeffrey T. La Belle, PhD
Grand Canyon University, Phoenix, Arizona, USA

10:45

Microneedle Sensing of Insulin and Ketones

Hazhir Teymourian, PhD
AquilX Inc., San Diego, California, USA

11:00

Continuous Ketone Monitoring Update

Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA

11:15

Q&A / Panel Discussion

11:40

Lunch

WORKSHOP B: VIRTUAL DIABETES CARE

PANEL 1: TECHNICAL BARRIERS (1.5 CME Credits)

What are the greatest technical barriers to widespread adoption of virtual diabetes care?

12:40

Moderators

Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA

Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany

12:45

Bridging the Telemedicine Divide

Tejaswi Kompala, MD
Teladoc Health; University of California, San Francisco, San Francisco, California, USA

13:00

Technology Literacy

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

13:15

Secure Authentication for Diabetes Devices

Shahid N. Shah, MSc
Netspective Communications LLC, Landover, Maryland, USA

13:30

Cybersecurity of Diabetes Devices

David N. Kleidermacher, BS
Google, Mountain View, California, USA

13:45

Privacy of Diabetes Devices

Randi E. Seigel, JD
Manatt, Phelps & Phillips LLP, New York, New York, USA

14:00

Q&A / Panel Discussion

14:20

Break

PANEL 2: CLINICAL BARRIERS (1.75 CME Credits)

What are the greatest clinical barriers to widespread adoption of virtual diabetes care?

14:45

Moderators

Andjela Drincic, MD
University of Nebraska Medical Center, Omaha, Nebraska, USA

Rosemary G. Oshinsky, RN, CDE, MSN
New Life New U Holistic Diabetes Care, Bethesda, Maryland, USA

14:50

Delivering Diabetes Care in a Direct-to-Consumer Model

Erich S. Huang, MD, PhD
Verily Life Sciences, South San Francisco, California, USA; Duke University School of Medicine, Durham, North Carolina, USA

15:05

Big Data and AI for Adaptive and Individualized Diabetes Management

Pavitra Krishnaswamy, PhD
A*STAR Institute for Infocomm Research, Singapore

15:20

The Evolving Role of Virtual Care During the Pandemic

Ateev Mehrotra, MD, MPH
Harvard Medical School, Boston, Massachusetts, USA

15:35

Delivering Telehealth to a County Hospital Population

Wei-An (Andy) Lee, DO
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA

15:50

The Payer Perspective on Telehealth

Jordan Silberman, MD, PhD
Carelon Digital Platforms (part of Elevance Health), Palo Alto, California, USA

16:05

Q&A / Panel Discussion

16:30

End of Workshop

Friday, November 4, 2022

INTRODUCTION (0.5 CME Credits)

8:00

Introduction

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05

Keynote Presentation: FDA and Diabetes Technology

Jeffrey E. Shuren, MD, JD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silverspring, Maryland, USA

8:25

Q&A

SESSION 1: METRICS FOR MANAGING DIABETES AND PREDICTING OUTCOMES (1.25 CME Credits)

How will CGM data be interpreted in the future?

8:30

Moderators

Viswanathan Mohan, MD, PhD, DSc
Dr. Mohan’s Diabetes Specialities Centre, Chennai, India; Madras Diabetes Research Foundation, Chennai, India

Jennifer L. Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA

8:35

Advances in CGM Data Science

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

8:50

The GRI: A New Composite Metric for Assessing the Quality of Glycemia of a CGM

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

9:05

Statistical Basis for the GRI

Michael A. Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA

9:20

CGM Data in People Without Diabetes

Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

9:35

Q&A / Panel Discussion

9:55

End of Session

SESSION 2: INTEGRATION OF CGM DATA INTO THE EHR (1.0 CME Credits)

How can the EHR be improved to better accommodate diabetes data?

9:55

Moderators

Richard M. Bergenstal, MD
International Diabetes Center at Park Nicollet, Minneapolis, Minnesota, USA

Priya Prahalad, MD, PhD
Stanford University, Stanford, California, USA

Presentation of Diabetes Technology Leadership Award

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

10:00

The Stenopool Database

Christian Selmer, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark

10:15

iCoDE: A New Standard for Integration of CGM Data into the EHR

Juan Espinoza, MD, FAAP
Children’s Hospital Los Angeles, University of Southern California, Los Angeles, California, USA

10:30

New Tools for Data Management

Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospitals & Clinics, Kansas City, Missouri, USA

10:45

Q&A / Panel Discussion

10:55

Break

SESSION 3: REGULATION OF DIABETES TECHNOLOGY (1.25 CME Credits)

What are the trends in regulation of diabetes technology?

11:20

Moderators

Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA

Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA

11:25

Regulation of Glucose Monitoring Systems

Yiduo Wu, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA

11:35

Regulation of Human-in-the-System Features of an Automated Insulin Delivery System

Zane Arp, PhD
United States Food and Drug Administration, Silver Spring, Maryland, USA

11:45

Trends in Digital Health Regulation

Bradley M. Thompson, JD, MBA, MADS
Epstein Becker Green PC, Washington, D.C., USA

11:55

Regulation of Digital Health Tools

Brendan O’Leary, BSME
United States Food and Drug Administration, Silver Spring, Maryland, USA

12:05

Q&A / Panel Discussion

12:25

Lunch

SESSION 4: DIGITAL HEALTH TO NUDGE BEHAVIOR (Non-Accredited Education)

How can digital health tools improve adherence to diabetes treatment?

13:10

Moderators

William T. Cefalu, MD
NIDDK/NIH, Bethesda, Maryland, USA

Victoria C. Hsiao, MD, PhD
University of California, San Francisco, San Francisco, California, USA

13:15

Digital Health Tools to Improve Patient Engagement

Felix Lee, MPharm, MSc, MBA
Sanofi, Bridgewater, New Jersey, USA

13:30

Better Behavior in Diabetes

Matthew E. Kahn, PhD
University of Southern California, Los Angeles, California, USA

13:45

New Metrics and Methods for Delivering Digital Health Interventions

Elizabeth Holt, MD, FACE
LifeScan Global Corporation, Malvern, Pennsylvania, USA

14:00

Behavioral Economics for Improving Adherence

Susana R. Patton, PhD
Nemours Children’s Health, Jacksonville, Florida, USA

14:15

Q&A / Panel Discussion

14:25

End of Session

SESSION 5: ESTIMATING CARBOHYDRATES (Non-Accredited Education)

How can technology estimate food intake by persons with diabetes?

14:25

Moderator

Thanh D. Hoang, DO
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA

14:30

Multimedia Data-Based Mobile Applications for Dietary Assessment

Stavroula G. Mougiakakou, PhD
University of Bern, Bern, Switzerland

14:45

Predicting the Macronutrient Composition of Mixed Meals from Dietary Biomarkers

Ricardo Gutierrez-Osuna, PhD
Texas A&M University, College Station, Texas, USA

15:00

Sensors for Detecting Food Intake

Samantha Kleinberg, PhD
Stevens Institute of Technology, Hoboken, New Jersey, USA

15:15

Q&A / Panel Discussion

15:25

Break

SESSION 6: ALGORITHMS FOR FULLY AUTOMATED INSULIN DELIVERY SYSTEMS (1.0 CME Credits)

What are promising trends in controlling automated insulin delivery systems?

15:50

Moderators

Jeffrey Joseph, DO
The Artificial Pancreas Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Rayhan A. Lal, MD
Stanford University, Stanford, California, USA

Presentation of Artificial Pancreas Award

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

15:55

Dual Closed-Loop and SGLT-2 Inhibitor Control

Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA

16:05

Building a Full Closed-Loop Algorithm: Insulin Timing Is the Key

Marc D. Breton, PhD
University of Virginia, Charlottesville, Virginia, USA

16:15

RocketAP in Practice: Results from Pilot and Feasibility Trials

José F. García-Tirado, PhD
University of Virginia, Charlottesville, Virginia, USA

16:25

Learning and Adaptation for Improved Control of the Artificial Pancreas

Frank J. Doyle, PhD
Harvard University, Cambridge, Massachusetts, USA

16:35

Fully Automated Insulin and Pramlintide Delivery System

Ahmad Haidar, PhD
McGill University, Montréal, Québec, Canada

16:45

Q&A / Panel Discussion

17:00

End of Session

Saturday, November 5, 2022

SESSION 7: TECHNOLOGY FOR DIAGNOSING HYPOGLYCEMIA (Non-Accredited Education)

How can new technology diagnose and prevent hypoglycemia?

8:00

Moderators

Maya Fayfman, MD
Emory University, Atlanta, Georgia, USA

Brian M. Frier, BSc, MD, FRCP
The University of Edinburgh, Edinburgh, UK

Presentation of Student Research Awards

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05

Prevention of Rebound Hypoglycemia in an Advanced Automated Insulin Delivery System

Maria F. Villa-Tamayo, MSc
University of Virginia, Charlottesville, Virginia, USA

8:20

The Role of Self-Monitoring of Blood Glucose in Diagnosing Hypoglycemia

Michelle F. Magee, MD
Georgetown University, Washington, D.C., USA; MedStar Diabetes Institute, Washington, D.C., USA

8:35

The Hypo-RESOLVE Project

Bastiaan E. de Galan, MD, PhD
Maastricht University Medical Centre, Maastricht, Netherlands; Radboud University Medical Centre, Nijmegen, Netherlands

8:50

Clinical Implications of Low Sensor Glucose

Pratik Choudhary, FRCP, MD, MRCP, MBBS
University of Leicester, Leicester, UK

9:05

EKG Diagnosis of Hypoglycemia

Sara Bachmann, MD
University Children’s Hospital Basel, Basel, Switzerland

9:20

Q&A / Panel Discussion

9:30

End of Session

SESSION 8: NOVEL INSULINS AND INSULIN DELIVERY (Non-Accredited Education)

How can technology improve insulin delivery?

9:30

Moderators

Barry H. Ginsberg, MD, PhD
Diabetes Technology Consultants, Arlington, Virginia, USA

Gerold M. Grodsky, PhD
University of California at San Francisco, San Francisco, California, USA

9:35

Tirzepatide Physiology

William C. Roell, PhD
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA

9:50

Ultralong and Ultrarapid Insulins

Tim Heise, MD
Profil Institute for Clinical Research, Neuss, Germany

10:05

Intraperitoneal Insulin Delivery

Eric Renard, MD, PhD, FRCP (Edin)
Lapeyronie Montpellier University Hospital, University of Montpellier, Montpellier, France

10:20

Advances in Smart Pens and Caps for Insulin Delivery

Johan H. Jendle, MD, PhD
Örebro University Hospital, Örebro, Sweden

10:35

Q&A / Panel Discussion

10:50

Break

SESSION 9: NOVEL ON-BODY SENSORS FOR DIABETES (Non-Accredited Education)

What are promising new types of sensors and measurements of interest for monitoring diabetes?

11:15

Moderators

Rodolfo J. Galindo, MD, FACE
Emory University, Atlanta, Georgia, USA

Irl B. Hirsch, MD, MACP
University of Washington, Seattle, Washington, USA

11:20

Measurement of Sweat Glucose and Lactate

Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA

11:30

Sleep Sensors for Monitoring Diabetes

Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

11:40

Cardiac Autonomic Neuropathy Sensors for Diabetes

Christian S. Hansen, MD, PhD
Steno Diabetes Center Copenhagen, Birkerød, Denmark

11:50

EEG Findings in Hypoglycemia

Maria Rubega, PhD
University of Padova, Padova, Italy

12:00

Q&A / Panel Discussion

12:10

Lunch

SESSION 10: ADVANCES IN CGM TECHNOLOGY (Non-Accredited Education)

What are important advances in CGM technology contained in commercial products?

12:55

Moderators

Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand

Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA

13:00

Abbott Technology

Marc B. Taub, PhD
Abbott Diabetes Care, Alameda, California, USA

13:12

Dexcom Technology

Peter Simpson, MS
Dexcom Inc., San Diego, California, USA

13:24

Medtronic Technology

Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, US

13:36

Senseonics Technology

Francine R. Kaufman, MD
Senseonics Inc., Germantown, Maryland, USA

13:48

Q&A / Panel Discussion

14:10

End of Session

SESSION 11: DIGITAL HEALTH TOOLS TO PREVENT DIABETIC FOOT ULCERS: ACHIEVING SUCCESS BY UNDERSTANDING DEFEAT (Non-Accredited Education)

What types of sensing and treatment technologies can improve outcomes for foot ulcers in diabetes?

14:10

Moderators

David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA

Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA

14:15

National Science Foundation’s Center to Stream Healthcare in Place (C2SHiP.org)

David G. Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA

14:25

Digital Health-led Decentralization for Managing Diabetic Foot Syndrome

Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA

14:35

Noninvasive Monitoring for Tissue Oxygenation

Anuradha Godavarty, PhD
Florida International University, Miami, Florida, USA

14:45

Q&A / Panel Discussion

14:55

Break

SESSION 12: HOT TOPICS (0.75 CME Credits)

What are some emerging areas of interest in the field of diabetes technology?

15:20

Moderators

Halis K. Aktürk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

Umesh Masharani, MD
University of California, San Francisco, San Francisco, California, USA

15:25

Diabetes and the Environment

Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia

15:35

Diabetes Technology and the Environment

Lutz Heinemann, PhD
Science Consulting in Diabetes, Kaarst, Germany

15:45

Spinal Cord Stimulation for Painful Diabetic Neuropathy

Erika A. Petersen, MD, FAANS, FACS
University of Arkansas, Little Rock, Arkansas, USA

15:55

Q&A / Panel Discussion

16:05

End of Session

LIVE DEMONSTRATION (0.25 CME Credits)

How does a new product with novel technology function?

16:05

Moderators

Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA

16:10

A Novel Product For Greener Diabetes Technology

Brian Brandell, PhD, MBA
Hemingway Designs LLC, Oregon City, Oregon, USA

Colt Stuart, BSME
Hemingway Designs LLC, Oregon City, Oregon, USA

16:25

Q&A

16:30

Closing Statements

Wednesday, November 9, 2022

PRODUCT THEATERS (Non-Accredited Education)

10:00

MannKind Product Theater: Ready. Set. Inhale: Clinical Update on AfrezzaFree Recording

Jennifer T. Rittenberry, MD, FACE
MannKind, Westlake Village, California, USA

10:30

Dexcom Product Theater: Introducing the all new Dexcom G7Free Recording

Grazia Aleppo, MD, FACE, FACP
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

11:30

End of Product Theater Sessions

Thursday, November 10, 2022

Poster Sessions (Non-Accredited education)Free Recording

Session A

Moderators

John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA

8:30 Use of Ultra-Rapid Insulin Lispro with a Full Closed-Loop Insulin Delivery System: An In Silico Analysis

Jenny L. Diaz C., PhD, et al.

Presented by: Patricio Colmegna, PhD

8:34 Simdex Enables First-in-Human Trials of a Novel Automated Insulin Delivery System at Home

Stephen Patek, PhD

8:38 Prevention of Rebound Hypoglycemia in an Advanced Automated Insulin Delivery System

Maria Fernanda Villa-Tamayo, MS

8:42 Comparing Different Individualized Black-Box Models for Insulin Pump Faults Detection on Artificial Pancreas Data

Eleonora Manzoni, MSc et al.

8:46 Feasibility of a Prototype Dual Function Glucose Sensing and Insulin Delivering Cannula

Cheng Yi Yuan, MD et al.

8:50 Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes

Carol J. Levy, MD, CDCES et al.

8:54 Q&A / Panel Discussion

9:15 End of Session

Session B

Moderators

Bruce Buckingham, MD
Stanford University, Stanford, California, USA

Jenise C. Wong, MD, PhD
University of California, San Francisco, San Francisco, California, USA

9:15 Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Combination with Bolus Insulin in Individuals with Type 2 Diabetes on Basal-Bolus Regimens (ONWARDS 4)

Chantal Mathieu, MD, PhD et al.

9:19 A Novel Infusion Failure Detection Paradigm Based on Fluid Pressure and Supervised Learning

Luis E. Blanco, BChE et al.

9:23 Insulin Pump Disruption: Cause and Effect

Alexander M. Markov, MD et al.

9:27 In Vitro Validation of an Open Source, Ultra-Low-Cost (<US$100) Insulin Pump

Matthew Payne, BE(Hons) et al.

9:31 Ultra Low Cost, Ultra Low Power, Open Source Clockwork Insulin Pump

Francis Pooke, BE(Hons) et al.

9:35 Inhaled Insulin + AID Safely Reduced Glucose in the 2 Hours Following a Meal in Proof-of-Concept Study Data Subset

Kevin Kaiserman, MD et al.

9:39 Q&A / Panel Discussion

10:00 End of Session

Session C

Moderators

Ibrahim A. Hashim, MSc, PhD, DABCC, FIBMS, CSc, FACB
UT Southwestern, Dallas, Texas, USA

Andreas Thomas, PhD
Freelance Scientific Consultant, Pirna, Germany

10:00 Next Generation Glucose Reference Platform - Data Supporting the Use of the Radiometer ABL90 Analyzer

Alejandra M. Pulido, MD et al.

10:04 Machine Learning Based Models for Estimating CGM Accuracy to Venous Plasma Glucose from Accuracy to Capillary Glucose

Arnaud Jacquin, PhD et al.

10:08 User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Results

Stefan Pleus, MSc et al.

10:12 Open Access, Light Based, Wearable Glucose Sensor – a Low-Cost Equitable APS

Josephine A. Dixon, BE(Hons) et al.

10:16 Comparison of POCT Devices to Glucose Isotope Dilution Gas Chromatography - Mass Spectrometry Reference Measurement Procedure

Komal Dahya, BS et al.

10:20 Improving the Quality of Glucose Concentration Measurements by Recalibration

Stefan Pleus, MSc et al.

10:24 Q&A / Panel Discussion

10:45 End of Session

Session D

Moderators

Julia Mader, MD
Medical University of Graz, Graz, Germany

Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA

10:45 Real-World Digital Health Data Demonstrate the Utility of The Glycemia Risk Index (GRI) as a Composite CGM Metric

Junjie Luo, PhD et al.

Presented by: Mansur Shomali, MD, CM

10:49 Imputation Model for Glucose Values Out of Measuring Range for Continuous Glucose Monitoring

Mikkel T. Olsen, MD et al.

10:53 Development of Derivatization-Free ID-LC/MS/MS Method for Simultaneous Measurement of Human Serum Monosaccharides

Chui Y. Tse, MS et al.

10:57 Translating event history to expected glucose distribution

Mrunal Sontakke, B.S et al.

11:01 The Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): An Illustrative Method for Continuous Glucose Monitoring System Accuracy Assessment

Manuel Eichenlaub, PhD et al.

11:05 Delivering Insulin by Glucose-Responsive Polymer-Based Microneedle Patch

Jackie F. Liu, B.Tech et al.

11:09 Q&A / Panel Discussion

11:30 End of Session

Session E

Moderators

Guillermo A. Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA

Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA

11:30 Smart Insulin Therapy Initiation in Insulin-Naïve Subjects with Type 2 Diabetes Using Machine Learning

Jacopo Bonet, MS et al.

11:34 Long-Term Glycemic and Patient-Reported Outcomes in Older Adults with Type 1 Diabetes Using Control-IQ Technology

Steph Habif, EdD, MS et al.

11:38 Diabetes Phenotypes Quantified via a Physiofunctional Model Fitted to Raw CGM Time Series Data

Robert Capps, PhD et al.

11:42 Simulating the Impact of Diabetes Therapy Engagement on Outcomes

Lane Desborough, MScEng et al.

11:46 Correlation of Hemoglobin A1c and Continuous Glucose Monitor Metrics in Diverse Populations of Youth with Diabetes

Meryl Nath, BA et al.

11:50 InPen™ System Use and Glycemic Outcomes in Older Adults

Glen H. Im, MS et al.

11:54 Q&A / Panel Discussion

12:15 End of Session

Session F

Moderators

Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA

Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia

12:15 Effect of Mobile Application Usage on TIR and TAR Within People with T1D and T2D: A Pilot Cohort Retrospective Study

Mikhalina Akulova, MSc et al.

12:19 Smartphone Camera to Image the Retina for Primary Care MDs and Diabetologists

Ethan Hintz et al.

12:23 Free Diabetes Apps and Health Literacy for Diabetic Patients

Kayla Israni et al.

12:27 Social Network Analysis of Diabetes and Glucose Monitoring Systems on Twitter Informed by ADCES7™ Framework

Nishant R. Jain, MS et al.

12:31 The Use of a Combined Real-Time CGM and Digital Health Solution Lowered A1C in People With Type 2 Diabetes

Abhimanyu Kumbara et al.

12:35 Sensor Controlled Diabetic Foot Ulcer Therapy – Next Generation Therapy of the Most Devastating Complication of Diabetes

Dirk Hochlenert, MD, PhD et al.

12:39 Q&A / Panel Discussion

13:00 End of Session